| Health / Medical Topics |
Vantictumab
A monoclonal antibody directed against the Wnt signaling pathway with potential antineoplastic activity. Upon administration, vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This may result in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. The Wnt signaling pathway is dysregulated in many cancer cell types and appears to play a major role in CSC regulation and activity; CSC are tumor initiating cells that are able to self-renew and are responsible for tumor growth and resistance. (NCI Thesaurus)
YOU MAY ALSO LIKE
The determination of the amount of vanillyl mandelic acid metabolite present in a sample.
A class of plant alkaloids which include the capsaicins
A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory…
A drug used to treat medullary thyroid cancer that has spread to other parts of the body and cannot be treated…
The mission of the Vanderbilt-Ingram Cancer Center is to alleviate cancer death and suffering through pioneering research, clinical trials, evidence-based patient-centered care,…
A group of bacterial species of the genus Enterococcus that is resistant to the antibiotic vancomycin.
